Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation01:24

One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation

1.1K
This lesson introduces two critical methods in pharmacokinetics, the Wagner-Nelson and Loo-Riegelman methods, used for estimating the absorption rate constant (ka) for drugs administered via non-intravenous routes. The Wagner-Nelson method relates ka to the plasma concentration derived from the slope of a semilog percent unabsorbed time plot. However, it is limited to drugs with one-compartment kinetics and can be impacted by factors like gastrointestinal motility or enzymatic degradation.
On...
1.1K
Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

217
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
217
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

361
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
361
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

214
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
214
Distributions to Estimate Population Parameter01:26

Distributions to Estimate Population Parameter

5.0K
The accurate values of population parameters such as population proportion, population mean, and population standard deviation (or variance) are usually unknown. These are fixed values that can only be estimated from the data collected from the samples. The estimates of each of these parameters are sample proportion, the sample mean, and sample standard deviation (or variance). To obtain the values of these sample statistics, data are required that have particular distribution and central...
5.0K
Estimating Population Mean with Unknown Standard Deviation01:22

Estimating Population Mean with Unknown Standard Deviation

8.7K
In practice, we rarely know the population standard deviation. In the past, when the sample size was large, this did not present a problem to statisticians. They used the sample standard deviation s as an estimate for σ and proceeded as before to calculate a confidence interval with close enough results. However, statisticians ran into problems when the sample size was small. A small sample size caused inaccuracies in the confidence interval.
William S. Gosset (1876–1937) of the...
8.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prevalent versus incident progressive supranuclear palsy: An analysis of the frequencies of neuropathological and clinical features at U.S. Alzheimer's Disease Research Centers indicate a relatively common tauopathy of aging.

Research square·2026
Same author

A Taxonomy of Data Synthesis.

Personality & social psychology bulletin·2026
Same author

Improving the clinical trial landscape for patients with atypical variants of Alzheimer's disease: a call to action.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

Frontal Release Signs and Future Decline in Research Participants With Intact Cognition.

JAMA network open·2026
Same author

GRN rs5848 variant associates with TDP-43 pathology and cancer in opposite directions.

Journal of neuropathology and experimental neurology·2026
Same author

Systematic contextual biases in SegmentNT potentially relevant to other nucleotide transformer models.

bioRxiv : the preprint server for biology·2026

Related Experiment Video

Updated: Jan 5, 2026

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

10.9K

Estimation of Multi-state Models with Missing Covariate Values Based on Observed Data Likelihood.

Wenjie Lou1,2, Erin L Abner2,3, Lijie Wan1,2

  • 1Department of Statistics, University of Kentucky, Lexington, KY.

Communications in Statistics: Theory and Methods
|October 26, 2019
PubMed
Summary

This study introduces an efficient method for handling missing risk factor data in multi-state disease models. The approach accurately estimates disease progression even with incomplete covariate information.

Keywords:
Longitudinal dataMARMCARmissing covariatemulti-state model

More Related Videos

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.7K
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.0K

Related Experiment Videos

Last Updated: Jan 5, 2026

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

10.9K
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.7K
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.0K

Area of Science:

  • Biostatistics
  • Epidemiology
  • Medical Statistics

Background:

  • Continuous-time multi-state models are vital for analyzing diseases with distinct stages.
  • Incorporating risk factors as covariates in these models is crucial for understanding disease dynamics.
  • Missing covariate data presents a significant challenge in real-world epidemiological studies.

Purpose of the Study:

  • To develop and evaluate a novel likelihood-based method for addressing missing covariate data in multi-state models.
  • To assess the performance of the proposed method under different missing data mechanisms.
  • To demonstrate the practical utility of the method using a real-world dataset.

Main Methods:

  • Development of a likelihood-based statistical framework to accommodate missing covariate measurements.
  • Simulation studies to evaluate method performance under 'missing completely at random' and 'missing at random' scenarios.
  • Application of the proposed method to the Einstein Aging Study dataset.

Main Results:

  • The proposed likelihood-based method efficiently handles missing covariate data in multi-state models.
  • Simulation results indicate good performance for both 'missing completely at random' and 'missing at random' data.
  • Successful application to the Einstein Aging Study, demonstrating practical feasibility.

Conclusions:

  • The developed method offers an effective solution for missing covariate data in continuous-time multi-state models.
  • This approach enhances the reliability of epidemiological analyses involving complex disease progression.
  • The method is robust and applicable to various aging and disease research contexts.